Indivior Pharmaceuticals (INDV) Notes Payables (2021 - 2023)
Indivior Pharmaceuticals (INDV) posted quarterly Notes Payables of $3.0 million for Q4 2023, little changed year-over-year from $3.0 million in Q4 2022, and little changed quarter-over-quarter from $3.0 million in Q4 2022.
Indivior Pharmaceuticals (INDV) Notes Payables (2021 - 2023) Analysis & Trends
Indivior Pharmaceuticals' Notes Payables history runs 3 years deep, the most recent figure standing at $3.0 million for Q4 2023.
- In Q4 2023, Notes Payables changed 0.0% year-over-year to $3.0 million; the TTM figure through Dec 2023 stood at $3.0 million (changed 0.0% YoY), while the FY2023 annual figure was $3.0 million, changed 0.0% from the prior year.
- Notes Payables for Q4 2023 stood at $3.0 million, roughly flat from $3.0 million in the prior quarter.
- The five-year high for Notes Payables was $3.0 million in Q4 2021, with the low at $3.0 million in Q4 2021.
- The 3-year median for Notes Payables is $3.0 million (2021), against an average of $3.0 million.
- Peak annual rise in Notes Payables reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Indivior Pharmaceuticals' Notes Payables stood at $3.0 million in 2021, then changed by 0.0% to $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023.
- Business Quant data shows INDV's Notes Payables at $3.0 million in Q4 2023, $3.0 million in Q4 2022, and $3.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.58 Bn | 4.36 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 3.00 Mn |